Follow
Katalin Dull
Katalin Dull
University of Debrecen, Department of Dermatology
Verified email at med.unideb.hu
Title
Cited by
Cited by
Year
Aurora kinase B expression in breast carcinoma: cell kinetic and genetic aspects
K Hegyi, K Egervári, Z Sándor, G Méhes
Pathobiology 79 (6), 314-322, 2012
742012
Genome wide analysis of TLR1/2-and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands
D Törőcsik, D Kovács, S Póliska, Z Szentkereszty-Kovács, M Lovászi, ...
PloS one 13 (6), e0198323, 2018
342018
Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy
K Hegyi, G Méhes
Pathology & Oncology Research 18, 761-769, 2012
302012
Factor XIII-A in diseases: role beyond blood coagulation
K Dull, F Fazekas, D Törőcsik
International Journal of Molecular Sciences 22 (3), 1459, 2021
182021
Occurrence and molecular pathology of high grade gliomas
B Murnyák, T Csonka, K Hegyi, G Méhes, A Klekner, T Hortobágyi
Ideggyogyaszati Szemle 66 (9-10), 312-321, 2013
17*2013
Epidermal growth factor modulates palmitic acid-induced inflammatory and lipid signaling pathways in SZ95 sebocytes
D Törőcsik, F Fazekas, S Póliska, A Gregus, EA Janka, K Dull, A Szegedi, ...
Frontiers in Immunology 12, 600017, 2021
132021
Isotretinoin is indirectly effective in sebocytes
D Kovács, K Hegyi, A Szegedi, D Deák, S Póliska, R Rühl, CC Zouboulis, ...
British Journal of Dermatology 182 (4), 1052-1054, 2020
102020
One-day FISH approach for the high-speed determination of HER2 gene copy status in breast carcinoma
K Hegyi, C Lønborg, A Mónus, G Méhes
Applied Immunohistochemistry & Molecular Morphology 21 (6), 567-571, 2013
102013
miR-146a modulates TLR1/2 and 4 induced inflammation and links it with proliferation and lipid production via the indirect regulation of GNG7 in human SZ95 sebocytes
K Dull, F Fazekas, D Deák, D Kovács, S Póliska, A Szegedi, CC Zouboulis, ...
Scientific reports 11 (1), 21510, 2021
92021
Mitotic index determined by phosphohistone H3 immunohistochemistry for precise grading in follicular lymphoma
J Bedekovics, G Irsai, K Hegyi, L Beke, L Krenács, L Gergely, G Méhes
Applied Immunohistochemistry & Molecular Morphology 26 (8), 579-585, 2018
92018
Primary uterine NK-cell lymphoma, nasal-type: a unique malignancy of a prominent cell type of the endometrium
G Méhes, K Hegyi, T Csonka, F Fazakas, Z Kocsis, G Radványi, I Vadnay, ...
Pathology & Oncology Research 18, 519-522, 2012
72012
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin
K Dull, K Lénárt, Z Dajnoki, S Póliska, E Uchiyama, Z Hendrik, A Szegedi, ...
Journal of the European Academy of Dermatology and Venereology 37 (7), 1415-1425, 2023
32023
Distinct Dynamics of Mitotic Transition in B-Cell Lymphoma and Reactive B-Cell Lymphoproliferations Determined by H3S10 Phosphohistone Immunolabeling
G Méhes, K Hegyi, R Jobanputra, L Beke, G Vereb, J Bedekovics
Pathobiology 84 (5), 243-250, 2017
32017
Mutant KRAS status is associated with increased KRAS copy number imbalance: a potential mechanism of molecular heterogeneity
O Dócs, K Hegyi, A Mokánszky, A Mónusné, L Beke, C András, ...
Pathology & Oncology Research 23, 417-423, 2017
32017
Linoleic Acid Induced Changes in SZ95 Sebocytes—Comparison with Palmitic Acid and Arachidonic Acid
D Kovács, E Camera, S Póliska, A Cavallo, M Maiellaro, K Dull, F Gruber, ...
Nutrients 15 (15), 3315, 2023
22023
Effect of a polyanion macromolecule on mitochondria DNA synthesis in isolated rat liver mitochondria.
G Szabados, V Ádám-Vizi, K Hegyi, I Horváth
Acta biochimica et biophysica; Academiae Scientiarum Hungaricae 14 (3), 155-164, 1979
21979
New Data on the Features of Skin Barrier in Hidradenitis Suppurativa
O Somogyi, Z Dajnoki, L Szabó, K Gáspár, Z Hendrik, CC Zouboulis, ...
Biomedicines 11 (1), 127, 2023
12023
Down‐regulation of increased TRAF 6 expression in the peripheral mononuclear cells of patients with primary Sjögren's syndrome by an EBV‐EBER 1‐specific synthetic single …
S Sipka, E Zilahi, G Papp, JQ Chen, A Nagy, K Hegyi, J Kónya, M Zeher
International Journal of Rheumatic Diseases 20 (5), 614-621, 2017
12017
Biologic mechanisms of mitotic abnormalities and chromosome number changes in malignant tumors
K Hegyi
Magyar Onkologia 59 (4), 365-371, 2015
12015
Mitotic kinase Aurora B is frequently overexpressed in aggressive B-cell lymphoma
K Hegyi, J Bedekovics, O Docs, G Irsai, L Gergely, L Beke, G Mehes
World Journal of Pathology 4 (4), 2015
12015
The system can't perform the operation now. Try again later.
Articles 1–20